Literature DB >> 10582888

Proton-pumping-ATPase-targeted antifungal activity of a novel conjugated styryl ketone.

E K Manavathu1, J R Dimmock, S C Vashishtha, P H Chandrasekar.   

Abstract

NC1175 (3-[3-(4-chlorophenyl)-2-propenoyl]-4-[2-(4-chlorophenyl)vinyle ne]-1- ethyl-4-piperidinol hydrochloride) is a novel thiol-blocking conjugated styryl ketone that exhibits activity against a wide spectrum of pathogenic fungi. Incubation of NC1175 with various concentrations of cysteine and glutathione eliminated its antifungal activity in a concentration-dependent fashion. Since NC1175 is a lipophilic compound that has the potential to interact with cytoplasmic membrane components, we examined its effect on the membrane-located proton-translocating ATPase (H(+)-ATPase) of yeast (Candida albicans, Candida krusei, Candida guilliermondii, Candida glabrata, and Saccharomyces cerevisiae) and Aspergillus (Aspergillus fumigatus, Aspergillus niger, Aspergillus flavus, and Aspergillus nidulans) species. The glucose-induced acidification of external medium due to H(+)-ATPase-mediated expulsion of intracellular protons by these fungi was measured in the presence of several concentrations of the drug. NC1175 (12.5 to 50 microM) inhibited acidification of external medium by Candida, Saccharomyces, and Aspergillus species in a concentration-dependent manner. Vanadate-inhibited hydrolysis of ATP by membrane fractions of C. albicans was completely inhibited by 50 microM NC1175, suggesting that the target of action of NC1175 in these fungi may include H(+)-ATPase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582888      PMCID: PMC89593          DOI: 10.1128/AAC.43.12.2950

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  57 in total

1.  ASPERGILLOSIS IN A CANCER HOSPITAL.

Authors:  R V HUTTER; P H LIEBERMAN; H S COLLINS
Journal:  Cancer       Date:  1964-06       Impact factor: 6.860

2.  Invasive candida infections--evolution of a fungal pathogen.

Authors:  J E Edwards
Journal:  N Engl J Med       Date:  1991-04-11       Impact factor: 91.245

Review 3.  Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

Authors:  D W Denning; D A Stevens
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

Review 4.  Aspergillus species colonization and invasive disease in patients with AIDS.

Authors:  K J Pursell; E E Telzak; D Armstrong
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

Review 5.  The emergence of fungi as major hospital pathogens.

Authors:  G P Bodey
Journal:  J Hosp Infect       Date:  1988-02       Impact factor: 3.926

6.  Defective H(+)-ATPase of hygromycin B-resistant pma1 mutants fromSaccharomyces cerevisiae.

Authors:  D S Perlin; S L Harris; D Seto-Young; J E Haber
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

7.  Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study.

Authors:  C S Pannuti; R D Gingrich; M A Pfaller; R P Wenzel
Journal:  J Clin Oncol       Date:  1991-01       Impact factor: 44.544

8.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.

Authors:  S N Banerjee; T G Emori; D H Culver; R P Gaynes; W R Jarvis; T Horan; J R Edwards; J Tolson; T Henderson; W J Martone
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

9.  In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.

Authors:  E K Manavathu; J R Dimmock; S C Vashishtha; J Cutright; P H Chandrasekar
Journal:  J Antimicrob Chemother       Date:  1998-11       Impact factor: 5.790

10.  Cloning and characterization of the plasma membrane H(+)-ATPase from Candida albicans.

Authors:  B C Monk; M B Kurtz; J A Marrinan; D S Perlin
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

View more
  6 in total

Review 1.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

2.  Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole.

Authors:  Javier Afeltra; Roxana G Vitale; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

3.  Antifungal Mechanism of Action of Lactoferrin: Identification of H+-ATPase (P3A-Type) as a New Apoptotic-Cell Membrane Receptor.

Authors:  María T Andrés; Maikel Acosta-Zaldívar; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

4.  The mechanism of antifungal action of essential oil from dill (Anethum graveolens L.) on Aspergillus flavus.

Authors:  Jun Tian; Xiaoquan Ban; Hong Zeng; Jingsheng He; Yuxin Chen; Youwei Wang
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

Review 5.  Promising Antifungal Targets Against Candida albicans Based on Ion Homeostasis.

Authors:  Yiman Li; Licui Sun; Chunyan Lu; Ying Gong; Min Li; Shujuan Sun
Journal:  Front Cell Infect Microbiol       Date:  2018-09-04       Impact factor: 5.293

6.  Antifungal activity of fused Mannich ketones triggers an oxidative stress response and is Cap1-dependent in Candida albicans.

Authors:  Tristan Rossignol; Béla Kocsis; Orsolya Bouquet; Ildikó Kustos; Ferenc Kilár; Adrien Nyul; Péter B Jakus; Kshitij Rajbhandari; László Prókai; Christophe d'Enfert; Tamás Lóránd
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.